FDA classifies oropharyngeal electrical stimulators as Class II medical devices
AI-generated summary for informational purposes only. Not legal advice. See the original source for the authoritative text.
The rule classifies oropharyngeal electrical stimulators as Class II medical devices, meaning they can be marketed under special safety and performance controls instead of the stricter Class III approval path. The FDA says this level of oversight is enough to give reasonable assurance that the devices are safe and effective. This matters for medical device manufacturers, clinicians, and patients because it may make these devices easier to bring to market while still requiring targeted safeguards. Companies developing or selling these stimulators will need to meet the FDA’s special controls for this device type.
AI-generated summary. May contain errors. Refer to official sources for legal decisions.
Key Changes
- Classifies oropharyngeal electrical stimulators as Class II medical devices
- Applies special controls designed to address safety and effectiveness risks
- Reduces the regulatory burden compared with automatic Class III treatment
Obligations
What this law requires
Manufacturers marketing an oropharyngeal electrical stimulator must comply with FDA Class II special controls applicable to this device type as part of the device’s classification requirements.